Clinical Trial Update: Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPC [Phase 3]

View source ↗

Summary

Phase 3 trial comparing nimotuzumab versus cisplatin with radiotherapy for locoregionally advanced nasopharyngeal carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Nimotuzumab (nimotuzumab)
• Radiotherapy

Snippet

Sponsor: Fudan University | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: COMPLETED